Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MSB
MSB logo

MSB Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
28.269
Open
28.269
VWAP
27.19
Vol
56.69K
Mkt Cap
229.47M
Low
26.280
Amount
1.54M
EV/EBITDA(TTM)
3.09
Total Shares
--
EV
288.43M
EV/OCF(TTM)
3.08
P/S(TTM)
3.22
Mesabi Trust is a royalty trust organized to derive income from an iron mine (the Peter Mitchell Mine) located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range. The Trust is a pass-through entity. It operates in one segment, which is iron ore mining. The mine is operated by Northshore Mining Company (Northshore), a subsidiary of Cleveland-Cliffs Inc. (CCI). Northshore mines the ore, which is in the form of taconite, a hard rock containing approximately 21% recoverable iron, crushes it, separates the iron particles from the non-metallic, and forms the resulting concentrate into pellets which are shipped for use in steel-producing blast furnaces of customers of CCI. Northshore pays royalties to the Trust primarily based on the selling price of pellets shipped from Northshore’s pellet plant at Silver Bay, Minnesota, on Lake Superior approximately 45 miles from the mine, plus a significantly smaller royalty based on tons of ore extracted at the mine.
Show More

Events Timeline

(ET)
2026-01-02
05:10:00
Mesoblast Appoints Philip Facchina as New Non-Executive Chair
select
2024-10-17 (ET)
2024-10-17
16:06:04
Mesabi Trust raises quarterly distribution to 39c per share from 35c
select
2024-09-11 (ET)
2024-09-11
12:00:45
Mesabi Trust rises 27.8%
select

News

moomoo
9.0
04-08moomoo
MESOBLAST GETS FDA IND APPROVAL TO INITIATE REGISTRATIONAL TRIAL FOR RYONCIL
  • Regulatory Approval: Mesoblast has received clearance from the FDA to proceed with a registration trial for the approval of Ryoncil.
  • Next Steps: The company will now move forward with the trial aimed at obtaining regulatory approval for the treatment.
moomoo
9.0
04-08moomoo
MESOBLAST LTD - FDA Approves RYONCIL IND for DMD Registration Trial
  • Company Overview: Mesoblast Ltd is a biotechnology company focused on developing innovative cell-based therapies for various medical conditions.

  • Regulatory Update: The company has received clearance from the FDA to proceed with a registration trial for its product in the field of regenerative medicine.

  • Trial Details: The upcoming trial will assess the efficacy and safety of Mesoblast's therapy in patients with specific medical conditions.

  • Market Impact: This regulatory approval is expected to enhance Mesoblast's market position and potentially lead to significant advancements in treatment options.

moomoo
9.5
04-07moomoo
MESOBLAST LTD - RYONCIL QUARTERLY NET REVENUE RISES TO US$30.3M
  • Company Overview: Mesoblast Ltd has reported a revenue increase for the quarter, reaching $30.3 million.
  • Financial Performance: The rise in revenue indicates positive growth and performance for the company during the specified period.
CNBC
2.0
03-13CNBC
Market Dynamics and Corporate Changes
  • Oil Price Fluctuations: Brent crude oil prices fell over 1% after surpassing $100 for the first time since August 2022, with the White House allowing purchases of sanctioned Russian oil at sea to alleviate supply disruptions from the Iran war, highlighting market sensitivity to energy supply issues.
  • Adobe CEO Transition: Shantanu Narayen, who has been CEO since 2007, will step down, as Adobe's annual recurring revenue growth fell short in Q1, leading to an over 8% drop in premarket shares, reflecting challenges in the SaaS market.
  • Salesforce Buyback Strategy: Salesforce plans to raise $25 billion in debt to fund stock repurchases, having previously increased its buyback authorization to $50 billion, indicating a strategic move to enhance shareholder value following a brutal sell-off earlier this year.
  • Lumentum Supply Constraints: Lumentum's CEO announced that the company is
seekingalpha
8.0
01-19seekingalpha
Mesabi Trust (MSB) Declares $0.26 Quarterly Dividend Payable February 20
  • Quarterly Dividend Announcement: Mesabi Trust declares a $0.26 per share dividend, reflecting the company's ongoing cash flow and profitability, which is likely to attract more investor interest.
  • Record Date for Shareholders: The record date for this dividend is set for January 30, meaning investors holding shares before this date will qualify for the dividend, enhancing short-term shareholder confidence.
  • Ex-Dividend Date Arrangement: The ex-dividend date is also set for January 30, requiring investors to purchase shares before this date to receive the dividend, which may lead to increased trading activity leading up to this date.
  • Payment Date Confirmation: The dividend will be paid on February 20, ensuring shareholders receive their returns promptly, further solidifying the company's reputation in the capital markets.
NASDAQ.COM
9.0
01-19NASDAQ.COM
Mesoblast Receives FDA Feedback for BLA Filing of rexlemestrocel-L
  • FDA Feedback: Mesoblast has received feedback from the FDA regarding its allogeneic cell therapy product, rexlemestrocel-L, indicating plans to file a Biologics License Application (BLA), marking a significant advancement in chronic discogenic low back pain treatment.
  • Clinical Trial Results: In the MSB-DR003 randomized controlled Phase 3 trial, the FDA acknowledged the efficacy of rexlemestrocel-L in reducing chronic low back pain, with significant pain intensity reduction observed at 12 months, potentially supporting product efficacy.
  • Labeling Update: The FDA noted that robust results on opioid use reduction from at least one adequate and well-controlled trial could be included in the Clinical Studies section of the product labeling, enhancing market competitiveness.
  • RMAT Designation: rexlemestrocel-L has been designated as a Regenerative Medicine Advanced Therapy (RMAT) by the FDA, providing all the benefits of Breakthrough and Fast Track programs, including rolling review and priority review eligibility, further accelerating the path to market.

Valuation Metrics

The current forward P/E ratio for Mesabi Trust (MSB.N) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Mesabi Trust's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding MSB

H
Horizon Kinetics Holding Corporation
Holding
MSB
+18.89%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Mesabi Trust (MSB) stock price today?

The current price of MSB is 27.03 USD — it has decreased -1.92

What is Mesabi Trust (MSB)'s business?

Mesabi Trust is a royalty trust organized to derive income from an iron mine (the Peter Mitchell Mine) located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range. The Trust is a pass-through entity. It operates in one segment, which is iron ore mining. The mine is operated by Northshore Mining Company (Northshore), a subsidiary of Cleveland-Cliffs Inc. (CCI). Northshore mines the ore, which is in the form of taconite, a hard rock containing approximately 21% recoverable iron, crushes it, separates the iron particles from the non-metallic, and forms the resulting concentrate into pellets which are shipped for use in steel-producing blast furnaces of customers of CCI. Northshore pays royalties to the Trust primarily based on the selling price of pellets shipped from Northshore’s pellet plant at Silver Bay, Minnesota, on Lake Superior approximately 45 miles from the mine, plus a significantly smaller royalty based on tons of ore extracted at the mine.

What is the price predicton of MSB Stock?

Wall Street analysts forecast MSB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Mesabi Trust (MSB)'s revenue for the last quarter?

Mesabi Trust revenue for the last quarter amounts to 4.74M USD, decreased -24.25

What is Mesabi Trust (MSB)'s earnings per share (EPS) for the last quarter?

Mesabi Trust. EPS for the last quarter amounts to USD, decreased -100.00

How many employees does Mesabi Trust (MSB). have?

Mesabi Trust (MSB) has 0 emplpoyees as of April 26 2026.

What is Mesabi Trust (MSB) market cap?

Today MSB has the market capitalization of 229.47M USD.